-
1
المؤلفون: null Olivier Tournilhac, null Magali Le Garff-Tavernier, null Stéphanie Nguyen Quoc, null Edouard Forcade, null Patrice Chevallier, null Faezeh Legrand-Izadifar, null Gandhi Laurent Damaj, null David Michonneau, null Cécile Tomowiak, null Cécile Borel, null Corentin Orvain, null Pascal Turlure, null Rabah Redjou, null Gaëlle Guillerm, null Laure Vincent, null Celestine Simand, null Richard Lemal, null Claire Quiney, null Patricia Combes, null Bruno Pereira, null Laure Calvet, null Aurélie Cabrespine, null Jacques-Olivier Bay, null Véronique Leblond, null Nathalie Dhédin, French Innovative Leukemia Organization (FILO), Société Francophone de Greffe De Moelle et de Thérapie Cellulaire (SFGM-TC)
المساهمون: Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne (UCA)
المصدر: Haematologica
Haematologica, Ferrata Storti Foundation, 2021, 106 (7), pp.1867-1875. ⟨10.3324/haematol.2019.239566⟩مصطلحات موضوعية: Oncology, medicine.medical_specialty, Neoplasm, Residual, Transplantation Conditioning, Chronic lymphocytic leukemia, medicine.medical_treatment, Phases of clinical research, Graft vs Host Disease, Hematopoietic stem cell transplantation, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, hemic and lymphatic diseases, medicine, Humans, Cumulative incidence, Prospective Studies, Retrospective Studies, business.industry, Hematopoietic Stem Cell Transplantation, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, medicine.disease, Donor Lymphocytes, Minimal residual disease, Leukemia, Lymphocytic, Chronic, B-Cell, 3. Good health, Regimen, Graft-versus-host disease, 030220 oncology & carcinogenesis, business, 030215 immunology